Announcements Trials
Browse Landscape

Phase

Phase 2 10Phase 3 7Phase 2/3 3Phase NA 1Phase 4 1Phase 1 1

Status

Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Cancer Type

Gastrointestinal 3

Conditions

Stomach Neoplasms 3Esophageal Neoplasms 1

Interventions

Oxaliplatin 11Docetaxel 8Fluorouracil 6Capecitabine 6Trastuzumab 5Leucovorin 5Drug Therapy 5apatinib 4S 1 (combination) 4Tegafur 3Paclitaxel 3Nivolumab 3Irinotecan 3Cisplatin 3sintilimab 2disitamab vedotin 2Surgical Procedures, Operative 2Standard of Care 2Ramucirumab 2Hyperthermic Intraperitoneal Chemotherapy 2Epirubicin 2vinflunine 1toripalimab 1titanium silicide 1tislelizumab 1taxane 1polysaccharide-K 1pertuzumab 1margetuximab 1gimeracil 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Phase 2/3 × Stomach Neoplasms × Tegafur × Clear all
NCT05325528 2023-02-01

Study of Tislelizumab in Combination With SOX for the Treatment of Gastric Cancer With Liver Metastases

Zhejiang University

Phase 2/3 Unknown
40 enrolled
Gastrointestinal

Stomach Neoplasms

NCT01516944 2020-02-13

Perioperative Chemotherapy for Potentially Resectable Gastric Cancer

Hebei Medical University

Phase 2/3 Completed
749 enrolled
Gastrointestinal

Stomach Neoplasms

NCT00503321 2009-01-23

eNCIT-Japan

Eastern Network of Cancer Immunological Therapy, Japan

Phase 2/3 Terminated
13 enrolled
Gastrointestinal

Stomach Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡